vs

Side-by-side financial comparison of AMBARELLA INC (AMBA) and Inogen Inc (INGN). Click either name above to swap in a different company.

AMBARELLA INC is the larger business by last-quarter revenue ($108.5M vs $68.6M, roughly 1.6× Inogen Inc). On growth, AMBARELLA INC posted the faster year-over-year revenue change (31.2% vs 3.4%). AMBARELLA INC produced more free cash flow last quarter ($31.4M vs $-1.9M). Over the past eight quarters, AMBARELLA INC's revenue compounded faster (45.0% CAGR vs 4.2%).

Ambarella, Inc. is an American fabless semiconductor design company, focusing on low-power, high-definition (HD) and Ultra HD video compression, image processing, and computer vision processors. Ambarella's products are used in a wide variety of human and computer vision applications, including video security, advanced driver assistance systems (ADAS), electronic mirror, drive recorder, driver and in-cabin monitoring, autonomous driving, and robotics applications. Ambarella's system on chips ...

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

AMBA vs INGN — Head-to-Head

Bigger by revenue
AMBA
AMBA
1.6× larger
AMBA
$108.5M
$68.6M
INGN
Growing faster (revenue YoY)
AMBA
AMBA
+27.8% gap
AMBA
31.2%
3.4%
INGN
More free cash flow
AMBA
AMBA
$33.3M more FCF
AMBA
$31.4M
$-1.9M
INGN
Faster 2-yr revenue CAGR
AMBA
AMBA
Annualised
AMBA
45.0%
4.2%
INGN

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
AMBA
AMBA
INGN
INGN
Revenue
$108.5M
$68.6M
Net Profit
$-15.1M
Gross Margin
59.6%
51.4%
Operating Margin
-15.0%
-13.6%
Net Margin
-13.9%
Revenue YoY
31.2%
3.4%
Net Profit YoY
37.2%
EPS (diluted)
$-0.35
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMBA
AMBA
INGN
INGN
Q4 25
$108.5M
$68.6M
Q3 25
$95.5M
$79.1M
Q2 25
$85.9M
$79.2M
Q1 25
$84.0M
$68.5M
Q4 24
$82.7M
$66.3M
Q3 24
$63.7M
$74.9M
Q2 24
$54.5M
$74.4M
Q1 24
$51.6M
$63.1M
Net Profit
AMBA
AMBA
INGN
INGN
Q4 25
$-15.1M
Q3 25
$-20.0M
$-5.3M
Q2 25
$-24.3M
$-4.2M
Q1 25
$-20.2M
$-6.2M
Q4 24
$-24.1M
Q3 24
$-34.9M
$-6.0M
Q2 24
$-37.9M
$-5.6M
Q1 24
$-60.6M
$-14.6M
Gross Margin
AMBA
AMBA
INGN
INGN
Q4 25
59.6%
51.4%
Q3 25
58.9%
52.2%
Q2 25
60.0%
52.2%
Q1 25
60.0%
53.1%
Q4 24
60.6%
54.7%
Q3 24
60.8%
55.2%
Q2 24
60.9%
57.4%
Q1 24
59.8%
54.5%
Operating Margin
AMBA
AMBA
INGN
INGN
Q4 25
-15.0%
-13.6%
Q3 25
-23.0%
-9.0%
Q2 25
-30.1%
-7.7%
Q1 25
-30.2%
-11.2%
Q4 24
-30.9%
-17.2%
Q3 24
-56.9%
-10.4%
Q2 24
-72.4%
-9.5%
Q1 24
-80.8%
-25.8%
Net Margin
AMBA
AMBA
INGN
INGN
Q4 25
-13.9%
Q3 25
-20.9%
-6.7%
Q2 25
-28.3%
-5.2%
Q1 25
-24.1%
-9.0%
Q4 24
-29.1%
Q3 24
-54.8%
-8.0%
Q2 24
-69.6%
-7.5%
Q1 24
-117.4%
-23.1%
EPS (diluted)
AMBA
AMBA
INGN
INGN
Q4 25
$-0.35
$-0.26
Q3 25
$-0.47
$-0.20
Q2 25
$-0.58
$-0.15
Q1 25
$-0.48
$-0.25
Q4 24
$-0.58
$-0.41
Q3 24
$-0.85
$-0.25
Q2 24
$-0.93
$-0.24
Q1 24
$-1.51
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMBA
AMBA
INGN
INGN
Cash + ST InvestmentsLiquidity on hand
$174.1M
$103.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$590.1M
$192.2M
Total Assets
$751.9M
$298.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMBA
AMBA
INGN
INGN
Q4 25
$174.1M
$103.7M
Q3 25
$142.7M
$106.5M
Q2 25
$141.3M
$103.7M
Q1 25
$144.6M
$118.9M
Q4 24
$127.1M
$113.8M
Q3 24
$153.9M
$105.7M
Q2 24
$131.8M
$97.9M
Q1 24
$144.9M
$107.4M
Stockholders' Equity
AMBA
AMBA
INGN
INGN
Q4 25
$590.1M
$192.2M
Q3 25
$576.5M
$197.2M
Q2 25
$572.7M
$199.5M
Q1 25
$561.4M
$198.0M
Q4 24
$554.3M
$173.9M
Q3 24
$547.6M
$185.4M
Q2 24
$555.4M
$187.6M
Q1 24
$559.9M
$191.9M
Total Assets
AMBA
AMBA
INGN
INGN
Q4 25
$751.9M
$298.6M
Q3 25
$706.4M
$307.0M
Q2 25
$701.9M
$312.0M
Q1 25
$689.0M
$308.4M
Q4 24
$670.8M
$296.2M
Q3 24
$650.3M
$306.2M
Q2 24
$638.7M
$308.9M
Q1 24
$657.7M
$315.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMBA
AMBA
INGN
INGN
Operating Cash FlowLast quarter
$34.3M
$-943.0K
Free Cash FlowOCF − Capex
$31.4M
$-1.9M
FCF MarginFCF / Revenue
29.0%
-2.8%
Capex IntensityCapex / Revenue
2.7%
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$64.3M
$-13.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMBA
AMBA
INGN
INGN
Q4 25
$34.3M
$-943.0K
Q3 25
$5.5M
$2.2M
Q2 25
$14.8M
$4.3M
Q1 25
$25.4M
$-16.8M
Q4 24
$6.6M
$-3.0M
Q3 24
$16.7M
$7.0M
Q2 24
$-15.0M
$6.7M
Q1 24
$-4.0M
$-4.7M
Free Cash Flow
AMBA
AMBA
INGN
INGN
Q4 25
$31.4M
$-1.9M
Q3 25
$1.4M
$1.6M
Q2 25
$10.2M
$3.7M
Q1 25
$21.2M
$-17.1M
Q4 24
$4.1M
$-3.3M
Q3 24
$14.2M
$5.3M
Q2 24
$-16.1M
$6.6M
Q1 24
$-6.0M
$-6.1M
FCF Margin
AMBA
AMBA
INGN
INGN
Q4 25
29.0%
-2.8%
Q3 25
1.4%
2.0%
Q2 25
11.9%
4.6%
Q1 25
25.3%
-24.9%
Q4 24
5.0%
-5.0%
Q3 24
22.2%
7.1%
Q2 24
-29.5%
8.9%
Q1 24
-11.6%
-9.6%
Capex Intensity
AMBA
AMBA
INGN
INGN
Q4 25
2.7%
1.4%
Q3 25
4.3%
0.7%
Q2 25
5.3%
0.9%
Q1 25
5.0%
0.4%
Q4 24
3.0%
0.5%
Q3 24
4.0%
2.2%
Q2 24
2.1%
0.1%
Q1 24
3.7%
2.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMBA
AMBA

TW$76.0M70%
Asia Pacific Other Than Taiwan$20.2M19%
North America Other Than United States$7.4M7%
Other$5.0M5%

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

Related Comparisons